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Backgrounds & Objective: The Helicobacter pylori prevalence has 
continuously decreased during recent years in Iran. The current study aimed at 
determining H. pylori prevalence in Neyshabur city, Northeast Iran, during 2010-
2015.  
Methods: The current epidemiologic survey was conducted in Neyshabur from 
2010 to 2015 to determine the prevalence of H. pylori infection. A total of 11596 
participants (3681 male with the mean age of 31.7±6.2 years and 7915 female with 
mean age of 68.3±4.7 years) were included. The enzyme-linked immunosorbent 
assay kits for the detection of H. pylori and Stat Fax 3200® Microplate Reader 
(USA) with a sensitivity of 95% and specificity of 98% were used. Titers above 12 
units were considered positive for IgG, IgA, and IgM (negative <8, equivocal 8 to 
12, and positive >12 U). The Chi-square t test and F test were used to analyze data.  
Results and Conclusion: The overall IgA, IgG, and IgM seropositive samples 
among the study participants were 852 (7.2%),  9000 (72.8%), and 1256 
(5.2%), respectively. The IgA seropositivity was significantly high among the age 
group above 51 years, compared with the other age groups. Moreover, the IgG and 
IgM seropositivity were significantly high among the age groups 41 to 50 and 31 to 
40 years respectively, compared with the other age groups. There was no 
significant difference between male and female cases regarding IgA and IgG 
seropositive samples, but IgM level was significantly higher among females, 
compared with that of the male cases. Furthermore, there was no significant 
alteration in IgA, IgG, and IgM seropositivity during 2010-2014 in Neyshabur.   
The prevalence of H. pylori in Neyshabur was high in the healthy population. 
Furthermore, the H. pylori prevalence did not change from 2010 to 2014 in the 
studied city. Effective approaches to improve health, educational, and 
socioeconomic status should be implemented to minimize and control H. 
pylori infection. 
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Introduction 
Helicobacter pylori (H. pylori) prevalence 
varies worldwide; however, it remains higher 
than 50% in many areas of the world including 
South America, East Europe and Asia. 
Helicobacter pylori is associated with gastro-
intestinal disorders, with important consequences 
of chronic gastritis, peptic ulcer that leads to 
gastric cancer, indigestion, and non-ulcer 
dyspepsia (1). In a review study on the 
prevalence and risk factors of H. pylori infection 
in the Middle East, it was demonstrated that H. 
pylori infection was high in the region, and in 
addition, the rate was higher among the patients 
with dyspepsia, those with histologically 
confirmed gastritis, and among the older age 
groups (2). It was determined that the prevalence 
of H. pylori was at the highest level in Turkey 
and Egypt (>80%), followed by Iran and Oman 
(70% and 80%, respectively) before 2013. 
Furthermore, the prevalence of duodenal ulcers, 
peptic ulcers, and gastritis among cagA+ 
individuals was 53% (95% confidence interval 
(CI): 20% to 86%), 65% (95%CI, 34% to 97%), 
and 71% (95%CI, 59% to 84%), respectively (3). 
OThe H. pylori infection transmission mainly 
occurs via interpersonal route; however, several 
other ways are suggested and not clearly 
explained. On the other hand, the prevalence 
among younger generations was low (4). A 
review and meta-analytic study showed that the 
mean prevalence of H. pylori was 50.7% during 
1994- 2011 with the lowest and highest 
prevalence in Tehran (19.2%) and Mazandaran 
(74.27%) provinces, respectively (5). A survey in 
Tehran showed that 87.6% of patients with 
dyspepsia were infected with H. pylori (6). 
Another study on 14 860 consecutive patients 
with gastritis in Tehran from 2008 to 2014 
determined that 83.5% of the cases were infected 
with H. pylori. In addition, a decline was 
observed in its prevalence during recent years (7). 
Several other studies from Asia and Middle East 
showed that H. pylori infection decreased in 
recent years (8, 9). The current study was 
performed to determine the prevalence of H. 
pylori infection in Neyshabur, Northeast Iran, 
during 2011-2015.  
Materials and Methods  
Sera samples 
The current epidemiologic, descriptive, cross 
sectional study was performed in Neyshabur, 
Northeast Iran, from 2010 to 2015 to determine 
the prevalence of H. pylori infection. A total of 
11 596 participants referred to the referral 
laboratory of Mashhad were included and sera 
samples (a 5-mL blood sample) were prepared 
and stored at -20ºC until use. 
ELISA test 
 The enzyme-linked immunosorbent assay 
(ELISA) kits for the detection of H. pylori 
(Pishtaz teb) and a Stat Fax 3200® Microplate 
Reader (USA) with the sensitivity of 95% and 
specificity of 98% were used. Any titer above 12 
units was considered positive for IgG, IgA, and 
IgM (negative <8, equivocal 8 to 12, and positive 
>12 U). 
Ethical Approval  
The current study protocol was approved by 
the Research and Technology, Deputy of Iranian 
Academic Center for Education, Culture, and 
Research (ACECR), Mashhad Branch.  
Data Analysis 
Data were analyzed by SPSS version 20 (IBM 
SPSS Statistics for Windows, Version 20, 
Armonk, NY, IBM Corp.); the Chi-square and F 
tests were employed. P-values <0.05 and F 
<0.001 were considered statistically significant.  
 
Results and Discussion  
 Out of 11 596 participants, 3681 were male 
and 7916 female. The mean age of the cases was 
45.39 ±15.4 years. Overall, 4500 (38.8%) cases 
indicated evidence of IgG seropositivity against 
H. pylori (ELISA IgG-Ab+), followed by 854 
(7.3%) cases for IgA and 600 (5.2%) for IgM. 
The levels of IgG antibody from 2010 to 2015 
were 73.6%, 67.9%, 72.4%, 75.6%, and 75.4%, 
respectively. These levels showed no significant 
or sensible change during the years of study, 
using F test (Pr>F, F>0.001). The IgA 
seropositivity was significantly high among the 
age group above 51 years, compared with the 
other age groups (F<0.001). Moreover, the IgG 
and IgM seropositivity were significantly high 
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among the age groups 41 to 50 and 31 to 40 
years, respectively (F<0.001). There was no 
significant difference between male and female 
cases regarding IgA and IgG seropositivity, but 
females had a significantly higher rate for IgM 
seropositivity, compared with that of the male 
cases (4.2 vs. 2.5, P=0.044). Furthermore, there 
was no significant alteration in IgA, IgG, and 
IgM seropositivity during 2011-2014 (tables 1 
and 2, Pr>F, F>0.001). Figures 1 and 2 show the 
level of antibodies and serum level (%) of 
antibodies, respectively.  
 
Table 1. The Relationship Between Antibody Titer, Age, and Gender - 2010-2015 
P-value 95% Cl 
Odds 
Ratio 
Seropositivity, N (%) 
No. (%) 
Demographic 
Features IgM IgG IgA 
Baseline 2 (1.3) 30 (19.3) 1 (0.6) 155(1.3) 0-10 
Age 
group 
(year) 
0.002 1.321-3.398 2.119 43 (4.71) 265 (29.1) 10(1.1) 912(7.9) 11-20 
<0.0001 2.864-7.104 4.511 108 (4.27) 959 (37.9) 85 (3.36) 2527(21.8) 21-30 
<0.0001 4.190-10.424 6.609 119 (4.22) 1155 (41) 140 (4.97) 2817(24.3) 31-40 
<0.0001 4.589-11.495 7.263 93 (3.82) 1022 (42) 149 (6.1) 2435(21) 41-50 
<0.0001 4.582-11.728 7.33 53 (3.3) 656 (40.4) 131 (8.1) 1623(14) 51-60 
<0.0001 3.201-8.296 5.153 24 (2.1) 413 (36.6) 112 (9.9) 1127(9.7) 61< 
0.653 0.908-1.062 0.982 
95 (2.5) 1440 (39.1) 222 (6) 3681(31.7) Male 
Gender 
347 (4.4) 3060 (38.7) 406 (5.13) 7915 (68.3) Female 
   442 (7.2) 4500(38.8) 628(5.3) 11596 (100)  Total 
 
  
Table 2. The Serum Levels of IgG and IgA against Helicobacter pylori During 2011-2014  
Year No. IgG Seropositivity, N (%) IgG Seronegativity, N (%) 
2014 762 575 (75.4) 187 (24.5) 
2013 1297 980 (75.6) 317 (24.4) 
2012 1195 866 (72.4) 329 (27.5) 
2011 1348 916 (67.9) 432 (32) 
2010 1583 1166 (73.6) 417 (26.3) 
Total 6185 4500 (72.8) 1682 (27.2) 
 
 
 
Fig 1. Age-based Distribution of Healthy Individuals in the Study  
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Fig 2. Number of IgA, IgG, and IgM Seropositive 
Cases of the Study 
 
It was the first study on H. pylori prevalence 
in Neyshabur, Northeastern Iran. Of the 11 596 
participants in the current study, 1681 (78.2%) 
had the evidence of IgG seropositivity, followed 
by 854 (7.3%) cases for IgA and 600 (5.2%) for 
IgM seropositivity against H. pylori using ELISA 
kits. The levels of IgG antibody from 2010 to 
2015 were 73.6%, 67.9%, 72.5%, 75.6%, and 
75.4%, respectively. These levels showed no 
significant or sensible change during the years of 
study. However, most of the previous studies 
showed that H. pylori prevalence gradually 
decreased in recent years in some areas of Iran 
and several other countries and that is increased 
with age (4, 5, 10-12). A study by Ashtari on 14 
860 patients revealed that 83.5% of the cases 
were infected with H. pylori. Moreover, the 
prevalence of bacteria in severe gastritis was 
significantly (P˂0.05) higher than those of mild 
or moderate statuses. It was concluded that its 
rate was high among Iranian population, but 
declined during recent years (7). Moreover, as 
depicted in Table1, the overall IgA, IgG, and IgM 
seropositive samples among different age groups 
of the current study were 442 (3.81%), 4500 
(38.8%), and 628 (2.31%), respectively. 
The IgA seropositivity was significantly high 
among the age group above 51 years. Moreover, 
the IgG and IgM seropositivity were significantly 
high among the age groups 41 to 50 and 31 to 40 
years, respectively. There was no significant 
difference between male and female cases 
regarding IgA and IgG seropositivity, but females 
had a significantly higher rate for IgM 
seropositivity, compared with that of male cases. 
Furthermore, there was no significant alteration 
in IgA, IgG, and IgM seropositivity from 2011 to 
2014. In a study by Nouraie on 2561 healthy 
individuals, the prevalence of H. pylori was 69% 
and was correlated with age increase in Tehran 
province, Iran (13). In another study by Alborzi, 
in Southern Iran, the prevalence of H. pylori were 
82%, 98%, 88%, 89%, and 58% among 9-month-
, and 2-, 6-, 10-, and 15-year-old cases, 
respectively, in which there was a significant 
decrease among the 15-year-old group (14). 
Moreover, gastric cancer, the most common type 
of cancer in the North and Northwest Iran, was 
also highly related to H. pylori infection, 
indicating a high prevalence of H. pylori in these 
areas (15). In a systematic review and meta-
analytic study by Eshraghian, the prevalence of 
H. pylori ranged from 22% to 87% among 
healthy populations in Iran and the other Eastern 
Mediterranean region countries (9). In another 
study by Khedmat, among the Middle Eastern 
countries, the prevalence of H. pylori was high 
and the rate seemed to be higher among patients 
with dyspepsia, patients with histologically 
confirmed gastritis, and also in patients of the 
elderly groups. Furthermore, Turkey and Egypt 
showed the highest rate of infection (>80%), in 
Iran and Oman it was 70% and 80%, respectively 
(2). On the other hand, it was revealed that the H. 
pylori prevalence was high among less 
economically advanced and populated countries. 
Moreover, the intrafamilial transmission may 
occur. Helicobacter pylori transmission through 
water showed controversial results (8). In the 
present study, the relationship of H. pylori IgA 
and IgG prevalence with age increase of 
individuals was significant (Table 1), but not for 
different genders. The rate of IgA, IgG, and IgM 
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seropositivity among the age group 0 to 10 years 
was 0.6%, 19.3%, and 1.3%, respectively, as the 
lowest level. The highest serum level of 
antibodies was observed among the age groups 
>6, 41 to 50, and 21 to 30 years old, respectively. 
Furthermore, the slight alteration in the level of 
IgG, IgA, and IgM antibodies during 2011-2014 
was insignificant.  
 
Conclusion  
 The prevalence of H. pylori in Neyshabur was 
high among the healthy population. Furthermore, 
the H. pylori prevalence did not change from 
2010 to 2014 in the studied city. These results 
highlighted the high risk among all of ages 
groups and possibility of transmission of the 
disease in this area. IgA seropositivity was 
significantly high among the age group above 51 
years, while the IgG and IgM seropositivity were 
significantly high among the age groups 41 to 50 
and 31to 40 years, respectively. IgM level was 
significantly higher among females, but not in 
case of IgA and IgG. Effective approaches to 
improve sanitary purposes, and educational and 
socioeconomic status should be implemented to 
minimize and control H. pylori infection.  
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